New study seeks to predict brain tumor changes with simple scans and blood tests
NCT ID NCT07447531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at whether special MRI scans and blood tests can help predict how a type of aggressive brain tumor (malignant glioma) changes over time. Researchers will follow 15 adults with newly diagnosed tumors, using imaging and blood samples to track certain iron-related markers. The goal is to better understand tumor progression, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict how aggressive brain tumors might change over time, potentially guiding treatment decisions.
What could go wrong
This is a very small, early observational study with only 15 people. It is not testing a treatment, so it may not lead to direct patient benefits. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa Health Care
RECRUITINGIowa City, Iowa, 52245, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••